Stocks to Watch
Drug giant Eli LillyLLY posted solid earnings gains Thursday, boosted by sales of its blockbusters. Lilly earned $692.2 million, or 64 cents a share, in the quarter, both up about 5% from a year ago on an 11% jump in revenue to $3.09 billion. Analysts had been forecasting earnings of 60 cents a share in the period. The company's schizophrenia medication Zyprexa did $1.05 billion in revenue, up 15%, while sales of its diabetes portfolio rose 4% to $640 million. The company expects to earn 65 cents to 67 cents a share in the third quarter and $2.50 to $2.60 a share in all of 2003, in line with analysts' forecasts. Sales will rise by a percentage in the low double-digits.
Yahoo! is among the most searched stocks on TheStreet.com. Here's what Cramer had to say about the stock recently.
Catch up on his thinking on the hottest topics of the past week.
Investors will have to deal with a Fed meeting and another flood of earnings and economic data.
Ensco International and Echelon have the potential to move higher in coming days.
See who made what calls.
The addition of video is helping telecom companies compete against cable and satellite companies.
The June West Texas Intermediate contract reflects selling pressure ahead of Tuesday's expiration. But stocks in the sector are generally trading higher.
See who made what calls.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Sponsored by:

ACCESS REALMONEY

